Canadian Cannabis: 1 Sector Immune to the Stock Market Crash

Canadian cannabis stocks could be resistant to the market crash. Here’s why names like Canopy Growth Corp (TSX:WEED)(NYSE:CGC) are a buy.

edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

The past year has seen profound changes for Canadian cannabis stocks in general. The overall long-term consensus is that there’s room for about four or five big names at the top — but which four or five they might be has changed repeatedly. Cash runways are now just as important as profitability to investors. The market has begun to mature, even if it hasn’t exactly stabilized yet.

Canadian cannabis: the perfect industry for the “new normal?”

Imagine an industry that could beat the market crash — a brand-new industry, not yet regulated at the U.S. federal level. An outsider industry that could bring in revenue for every city in every state, an outperforming industry with proven popularity that could beat the market.

An industry that is simply waiting to be legalized stateside so that it can start generating taxable revenue. That industry exists: it’s cannabis.

It’s easy to look at pot stocks through the filter of the current public health crisis and see their losses as being symptomatic. However, Canadian cannabis stocks have proved remarkably resilient to the coronavirus market crash.

The TSX Composite Index is down 20% in the past month. But Canopy Growth is down 19.8%. Who would have thought that a pot stock could beat the TSX in a market crash?

Go long on market-disrupting cannabis stocks

Canadian cannabis has seen its headwinds. But they could be flipped around and turned into tailwinds by U.S. legalization. The growth would be phenomenal, and some of our biggest names are already in position to capitalize.

Look at Canopy Growth with its Acreage Holdings deal and Constellation Brands leadership. Look at the CBD capabilities of HEXO, Aphria, Cronos Group, and more.

However, as cannabis investors will know, the past year hasn’t been plain sailing even for popular Canadian cannabis stocks. Village Farms, for instance, fell out with joint venture Pure Sunfarms co-owner, Emerald Health Therapeutics over supply agreements.

The dispute was duly settled, though, with Village Farms eventually upping its majority stake in Pure Sunfarms to 57.4% during its fourth quarter.

However, no other cannabis stocks offer the same unique mix of safety and growth potential. Village Farms remains a world-class vegetable producer, and even produces some clean electricity.

With around 80% upside potential, the majority owner of Pure Sunfarms is a long-term buy. This quality cannabis name now commands a 13.5% market share in the dried flower space.

This popular Canadian cannabis name, operating out of British Columbia, is on track for huge upside. Its 13.5% market share for dried flower makes Village Farms a top name to watch.

It’s a canny play if you’re looking for a smaller-cap name with masses of growth potential. The stock has an exceptionally solid outlook thanks to low overheads and huge CBD growth potential.

The bottom line

Pure Sunfarms is steadily capturing market share in the dried flower market. Investors looking to buy on extreme weakness have a strong play in this low cost, large-scale producer right now.

Canopy, Aphria, and Cronos are also strong long-term buys for market dominance.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Victoria Hetherington has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Village Farms International, Inc. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »